Eduardo H. Charreau - Concepedia

Author

Eduardo H. Charreau

Experimental Medicine and Biology Institute

Also Known As

Charreau, Eduardo Hernan, E CHARREAU, E Charreau, E H Charreau, E. Charreau, E. Charreau*, E. H. CHARREAU, E. H. Charreau, E.H. CHARREAU, E.H. Charreau

171

Publications

4.2K

Citations

H-Index

Concepts

All Affiliations

Experimental Medicine and Biology Institute Universidad de Buenos Aires Consejo Nacional de Investigaciones Científicas y Técnicas Fundación Ciencias Exactas y Naturales Sanatorio Otamendi y Miroli

About

Eduardo H. Charreau is an author at Experimental Medicine and Biology Institute specializing in medicine, cell biology, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	53	2.7K
2	Public Health	14	17	621
3	Health Sciences	2	2	65
4	Engineering	1	1	205
5	Natural Sciences	1	1	18

Eduardo H. Charreau

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Nitric oxide inhibits Leydig cell steroidogenesis. K. Del Punta, Eduardo H. Charreau, Omar P. Pignataro Endocrinology SpermatogenesisReproductive BiologyCgmp ProductionOxidative StressReproductive Endocrinology	1996	225
Measurement of specific radioactivities in labelled hormones by self-displacement analysis Juan Carlos Calvo, J. Pablo Radicella, Eduardo H. Charreau Biochemical Journal EngineeringGraphical MethodLabelled HormonesBioanalysisRadiopharmaceutical Therapy	1983	205
Characteristics of a Soluble Gonadotropin Receptor from the Rat Testis Maria Dufau, Eduardo H. Charreau, Kevin Catt Journal of Biological Chemistry Gonadal ReceptorFertilityGynecologyFemale Reproductive FunctionReproductive Biology	1973	176
TNFα acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-κB-dependent pathways Martín A. Rivas, Romina P. Carnevale, Cecilia J. Proietti, Experimental Cell Research Nf-κb-dependent PathwaysCancer ResearchBreast OncologyP42/p44 MapkSignaling Pathway	2007	157
Progestins Induce Transcriptional Activation of Signal Transducer and Activator of Transcription 3 (Stat3) via a Jak- and Src-Dependent Mechanism in Breast Cancer Cells Cecilia J. Proietti, Mariana Salatino, Cinthia Rosemblit, Molecular and Cellular Biology	2005	129
Inhibition of Follicle-Stimulating Hormone Receptor Binding by CirculatingImmunoglobulins* Violeta A. Chiauzzi, S.B. Cigorraga, Martha Escobar, The Journal of Clinical Endocrinology & Metabolism	1982	124
Prolactin binding in rat testis: Specific receptors in interstitial cells Eduardo H. Charreau, A. Attramadal, Peter A. Torjesen, Molecular and Cellular Endocrinology Signal TransductionPhysiologyImmunologyCytoskeletonEndocrinology	1977	121
Activation of ErbB-2 via a hierarchical interaction between ErbB-2 and type I insulin-like growth factor receptor in mammary tumor cells María Eugenia Balañá, Letícia Labriola, Mariana Salatino, Oncogene Breast OncologySignal TransductionSignaling PathwayReceptor Tyrosine KinaseMammary Tumor Cells	2001	118
Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3 Wendy Béguelin, María C. Díaz Flaqué, Cecilia J. Proietti, Molecular and Cellular Biology Breast Cancer GrowthBreast OncologyProgesterone ReceptorErbb-2 Nuclear TranslocationCancer Biology	2010	109
Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells Letícia Labriola, Mariana Salatino, Cecilia J. Proietti, Molecular and Cellular Biology Functional Erbb-2Progesterone ReceptorBreast OncologyTumor BiologyTranscriptional Regulation	2003	96

Page 1